SMARCA4 and non-small cell lung carcinoma: These findings indicate that the true prevalence and impact of BRG1-LOF in NSCLC could be higher than current estimates based on coding region mutations that ignore BRG1 loss due to mutations outside of the coding region and/or non-genetic (e.g., epigenetic) abnormalities.